Letter to the editor: Commending an insightful contribution to infectious complications in patients undergoing transrectal prostate-biopsy with Ciprofloxacin compared to fosfomycin-trometamol.

This study delivers a comprehensive retrospective analysis addressing the growing clinical concern of antimicrobial resistance in patients undergoing prostate biopsy. By evaluating prophylactic strategies in light of local resistance patterns and individual risk profiles, the authors highlight the limitations of standardized regimens and advocate for tailored, data-driven interventions. The findings not only enhance our understanding of infection prevention in urology but also reinforce the importance of antimicrobial stewardship and personalized care. This work contributes valuable insights that can inform evidence-based policy and improve patient safety in an increasingly cost-conscious and resistance-aware healthcare environment.